These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
532 related articles for article (PubMed ID: 31607902)
1. N-3 Polyunsaturated Fatty Acids and the Resolution of Neuroinflammation. Joffre C; Rey C; Layé S Front Pharmacol; 2019; 10():1022. PubMed ID: 31607902 [TBL] [Abstract][Full Text] [Related]
2. Specialized Pro-Resolving Mediators in Neuroinflammation: Overview of Studies and Perspectives of Clinical Applications. Valente M; Dentoni M; Bellizzi F; Kuris F; Gigli GL Molecules; 2022 Jul; 27(15):. PubMed ID: 35956787 [TBL] [Abstract][Full Text] [Related]
3. n-3 Polyunsaturated Fatty Acids and Their Derivates Reduce Neuroinflammation during Aging. Joffre C; Dinel AL; Chataigner M; Pallet V; Layé S Nutrients; 2020 Feb; 12(3):. PubMed ID: 32121189 [No Abstract] [Full Text] [Related]
4. Fish oil feeding attenuates neuroinflammatory gene expression without concomitant changes in brain eicosanoids and docosanoids in a mouse model of Alzheimer's disease. Hopperton KE; Trépanier MO; James NCE; Chouinard-Watkins R; Bazinet RP Brain Behav Immun; 2018 Mar; 69():74-90. PubMed ID: 29109025 [TBL] [Abstract][Full Text] [Related]
5. Pro-Resolving Lipid Mediators in the Pathophysiology of Asthma. Kytikova O; Novgorodtseva T; Denisenko Y; Antonyuk M; Gvozdenko T Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31216723 [TBL] [Abstract][Full Text] [Related]
6. Dietary n-3 long chain PUFA supplementation promotes a pro-resolving oxylipin profile in the brain. Rey C; Delpech JC; Madore C; Nadjar A; Greenhalgh AD; Amadieu C; Aubert A; Pallet V; Vaysse C; Layé S; Joffre C Brain Behav Immun; 2019 Feb; 76():17-27. PubMed ID: 30086401 [TBL] [Abstract][Full Text] [Related]
7. The Anti-Inflammatory Role of Omega-3 Polyunsaturated Fatty Acids Metabolites in Pre-Clinical Models of Psychiatric, Neurodegenerative, and Neurological Disorders. Giacobbe J; Benoiton B; Zunszain P; Pariante CM; Borsini A Front Psychiatry; 2020; 11():122. PubMed ID: 32180741 [TBL] [Abstract][Full Text] [Related]
8. Unesterified docosahexaenoic acid is protective in neuroinflammation. Orr SK; Palumbo S; Bosetti F; Mount HT; Kang JX; Greenwood CE; Ma DW; Serhan CN; Bazinet RP J Neurochem; 2013 Nov; 127(3):378-93. PubMed ID: 23919613 [TBL] [Abstract][Full Text] [Related]
9. Development of an Optimized LC-MS Method for the Detection of Specialized Pro-Resolving Mediators in Biological Samples. Kutzner L; Rund KM; Ostermann AI; Hartung NM; Galano JM; Balas L; Durand T; Balzer MS; David S; Schebb NH Front Pharmacol; 2019; 10():169. PubMed ID: 30899221 [TBL] [Abstract][Full Text] [Related]
10. Omega-3 Polyunsaturated Fatty Acids in Critical Illness: Anti-Inflammatory, Proresolving, or Both? Molfino A; Amabile MI; Monti M; Muscaritoli M Oxid Med Cell Longev; 2017; 2017():5987082. PubMed ID: 28694914 [TBL] [Abstract][Full Text] [Related]
11. Neuroimmunological effects of omega-3 fatty acids on migraine: a review. Chen TB; Yang CC; Tsai IJ; Yang HW; Hsu YC; Chang CM; Yang CP Front Neurol; 2024; 15():1366372. PubMed ID: 38770523 [TBL] [Abstract][Full Text] [Related]
12. Resolvins, Protectins, and Maresins: DHA-Derived Specialized Pro-Resolving Mediators, Biosynthetic Pathways, Synthetic Approaches, and Their Role in Inflammation. Ferreira I; Falcato F; Bandarra N; Rauter AP Molecules; 2022 Mar; 27(5):. PubMed ID: 35268778 [TBL] [Abstract][Full Text] [Related]
13. Specialized Pro-Resolving Lipid Mediators: The Future of Chronic Pain Therapy? Chávez-Castillo M; Ortega Á; Cudris-Torres L; Duran P; Rojas M; Manzano A; Garrido B; Salazar J; Silva A; Rojas-Gomez DM; De Sanctis JB; Bermúdez V Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638711 [TBL] [Abstract][Full Text] [Related]
14. An update on the role of omega-3 fatty acids on inflammatory and degenerative diseases. Lorente-Cebrián S; Costa AG; Navas-Carretero S; Zabala M; Laiglesia LM; Martínez JA; Moreno-Aliaga MJ J Physiol Biochem; 2015 Jun; 71(2):341-9. PubMed ID: 25752887 [TBL] [Abstract][Full Text] [Related]
15. Deciphering the Potential Role of Specialized Pro-Resolving Mediators in Obesity-Associated Metabolic Disorders. Kim N; Shin HY Int J Mol Sci; 2024 Sep; 25(17):. PubMed ID: 39273541 [TBL] [Abstract][Full Text] [Related]
16. Role of polyunsaturated fatty acids in ischemic stroke - A perspective of specialized pro-resolving mediators. Miao Z; Schultzberg M; Wang X; Zhao Y Clin Nutr; 2021 May; 40(5):2974-2987. PubMed ID: 33509668 [TBL] [Abstract][Full Text] [Related]
17. Is Lipid Metabolism of Value in Cancer Research and Treatment? Part II: Role of Specialized Pro-Resolving Mediators in Inflammation, Infections, and Cancer. Babar MU; Nassar AF; Nie X; Zhang T; He J; Yeung J; Norris P; Ogura H; Muldoon A; Chen L; Libreros S Metabolites; 2024 May; 14(6):. PubMed ID: 38921449 [TBL] [Abstract][Full Text] [Related]
18. Effects of maternal n-3 fatty acid supplementation on placental cytokines, pro-resolving lipid mediators and their precursors. Keelan JA; Mas E; D'Vaz N; Dunstan JA; Li S; Barden AE; Mark PJ; Waddell BJ; Prescott SL; Mori TA Reproduction; 2015 Feb; 149(2):171-8. PubMed ID: 25504868 [TBL] [Abstract][Full Text] [Related]
19. Specialized Pro-Resolving Mediators as Resolution Pharmacology for the Control of Pain and Itch. Ji RR Annu Rev Pharmacol Toxicol; 2023 Jan; 63():273-293. PubMed ID: 36100219 [TBL] [Abstract][Full Text] [Related]
20. New translational and experimental insights into the role of pro-resolving lipid mediators in inflammatory bowel disease. Pascoal LB; Palma BB; Chaim FHM; de Castro MM; Damázio TA; Franceschini APMF; Milanski M; Velloso LA; Leal RF World J Exp Med; 2022 Jan; 12(1):1-15. PubMed ID: 35096550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]